UnknownPhase 4ketamine
Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia
Sponsored by Hallym University Kangnam Sacred Heart Hospital
NCT ID
NCT02493231
Target Enrollment
60 participants
Start Date
2015-03
About This Study
Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.
Conditions Studied
Interventions
- •Nefopam
- •Ketamine
- •Saline
Eligibility
Age:20 Years - 65 Years
View full eligibility criteria
Inclusion Criteria: * patient who scheduled laparoscopic cholecystectomy under general anesthesia * American Society of Anesthesiologist(ASA) class I or II * adult patient (age 20 - 65) Exclusion Criteria: * patient who has liver disease * patient who has kidney disease * patient who has diabetes mellitus(DM) or heart disease * patient who takes opioid or beta-blocker * patient who has airway disease * patient who has allergy with the drug
Study Locations (1)
Hallym University Kangnam Sacred Heart Hospita
Seoul, South Korea